Pharmaceutical company Merck said Monday it will get a small, privately-held biotech firm that has actually developed a promising drug candidate for dealing with extreme cases of COVID-19
Read More
Pharmaceutical company Merck said Monday it will get a small, privately-held biotech firm that has actually developed a promising drug candidate for dealing with extreme cases of COVID-19
Read More